Celgene Announces Will Offer Findings from Long-Term Post-Hoc Analysis of Pooled Data from PALACE Phase III Trial of Otezla at EULAR

By: via Benzinga
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the findings from a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.